Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up

被引:11
|
作者
Behrangi, Elham [1 ]
Shemshadi, Mahsa [1 ]
Ghassemi, Mohammadreza [1 ]
Goodarzi, Azadeh [1 ]
Dilmaghani, Sara [1 ]
机构
[1] Iran Univ Med Sci IUMS, Dept Dermatol, Rasool Akram Med Complex Clin Res Dev Ctr RCRDC, Tehran, Iran
关键词
laser; melasma; microinjection; Q-switched; RCT; ALUMINUM-GARNET LASER; THERAPEUTIC-EFFICACY; ALEXANDRITE LASER; COMBINATION; TRIAL;
D O I
10.1111/jocd.14496
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Melasma is a common hyperpigmentation disorder. This study aimed to compare the efficacy of Nd-Yag fractional 1064 plus microinjection of tranexamic acid versus Nd-Yag fractional 1064 plus oral tranexamic acid in patients with melasma. Materials and methods This is a prospective, randomized study with a sample size of 40 patients, 20 in each treatment arm, which was done six times with 2-week intervals. Twenty patients were administered localized microinjections (4 mg/ml) of tranexamic acid and Q-switched 1064 laser every 2 weeks in one arm, while in the other arm, 20 were given oral tranexamic acid 250 mg three times a day and Q-switched 1064 laser every 2 weeks per visit. Results Twenty-one patients with mean SD 40.52+-4.95 y/o were treated with oral tranexamic acid, and 20 patients with 43.3+-5.87 y/o treated with microinjection of tranexamic acid were analyzed. There was no statistically significant difference between the two groups in terms of demographic and clinical characteristics at the baseline (p > 0.05). The patients MASI score and increment E decrease over the study period in both treatments significantly (p < 0.001). However, patient's MASI score (p = 0.99) and increment E (p = 0.53) did not differ significant between the two group over the time. Satisfaction (p = 0.41) and complication during the study period (p = 0.09) were not significantly different between the two group. Conclusion The combination treatment method can be a viable option for Middle Eastern patients having melasma disorder, and tranexamic acid appears to be an effective and safe treatment for melasma, irrespective of its route of administration. Tranexamic acid can increase the permeability locally by non-invasive methods such as microneedling which is less painful than microinjection and can also increase patient satisfaction. Although the oral method is more tolerable for the patient, it may have systemic side effects, and its combination with Q-switch laser increases its effect regardless of the type of prescription. Therefore, it is recommended to use of this drug topically (cream or lotion) by non-invasive methods like microneedling to reduce pain and laser treatment in future studies.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 50 条
  • [1] Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma
    Suh, Kee Suck
    Sung, Jae Young
    Roh, Hyo Jin
    Jeon, Young Seung
    Kim, Yang Che
    Kim, Sang Tae
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2011, 22 (04) : 233 - 238
  • [2] Efficacy of combination therapy using low fluence 1064-nm Q-switched Nd:YAG laser and tranexamic acid-based oral medication on melasma
    Park, Jihun
    Lee, Jungsoo
    Shin, Jung U.
    Oh, Sang Ho
    Lee, Ju Hee
    JOURNAL OF DERMATOLOGY, 2012, 39 : 12 - 12
  • [3] The efficacy of 1064-nm Q-switched Nd: YAG laser combined with tranexamic acid, glutathione, and vitamin C in the treatment of chloasma
    Chen, Xiaojian
    Wu, Jian
    Cai, Meihong
    Shi, Feng
    Wu, Lei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (11): : 12833 - 12839
  • [4] A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation
    Agamia, Naglaa
    Apalla, Zoi
    Salem, Walaa
    Abdallah, Wafaa
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (07) : 819 - 826
  • [5] Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation
    Elkamshoushi, Abdelaal M.
    Romisy, Doaa
    Omar, Salma S.
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (02) : 657 - 668
  • [6] Treatment of melasma with low fluence, 1064-nm Q-switched Nd:YAG laser in Chinese patients
    Liu Hua-xu
    Wang Jin-liang
    Wang Xin-yi
    Zhang Fu-ren
    JOURNAL OF DERMATOLOGY, 2012, 39 : 151 - 151
  • [7] Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma
    Laothaworn, Variya
    Juntongjin, Premjit
    JOURNAL OF COSMETIC AND LASER THERAPY, 2018, 20 (06) : 320 - 325
  • [8] Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser
    Tian, Wei Cheng Brian Anthony
    JOURNAL OF COSMETIC AND LASER THERAPY, 2016, 18 (02) : 72 - 74
  • [9] Efficacy and safety of 1064-nm Q-switched Nd:YAG laser with low fluence for keloids and hypertrophic scars
    Cho, S. B.
    Lee, J. H.
    Lee, S. H.
    Lee, S. J.
    Bang, D.
    Oh, S. H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (09) : 1070 - 1074
  • [10] Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study
    Zhou, Yanjun
    Li, Yong
    Hamblin, Michael R.
    Wen, Xiang
    LASERS IN SURGERY AND MEDICINE, 2024, 56 (03) : 263 - 269